High-Dependency Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero-Universitaria Careggi, Lg. Brambilla 3, 50134, Florence, Italy.
Intern Emerg Med. 2018 Apr;13(3):405-412. doi: 10.1007/s11739-017-1629-5. Epub 2017 Feb 10.
Several widely used scoring systems for septic patients have been validated in an ICU setting, and may not be appropriate for other settings like Emergency Departments (ED) or High-Dependency Units (HDU), where a relevant number of these patients are managed. The purpose of this study is to find reliable tools for prognostic assessment of septic patients managed in an ED-HDU. In 742 patients diagnosed with sepsis/severe sepsis/septic shock, not-intubated, admitted in ED between June 2008 and April 2016, SOFA, qSOFA, PIRO, MEWS, Charlson Comorbidity Index, MEDS, and APACHE II were calculated at ED admission (T0); SOFA and MEWS were also calculated after 24 h of ED-High-Dependency Unit stay (T1). Discrimination and incremental prognostic value of SOFA score over demographic data and parameters of sepsis severity were tested. Primary outcome is 28-day mortality. Twenty-eight day mortality rate is 31%. The different scores show a modest-to-moderate discrimination (T0 SOFA 0.695; T1 SOFA 0.741; qSOFA 0.625; T0 MEWS 0.662; T1 MEWS 0.729; PIRO: 0.646; APACHE II 0.756; Charlson Comorbidity Index 0.596; MEDS 0.674, all p < 0.001). At a multivariate stepwise Cox analysis, including age, Charlson Comorbidity Index, MEWS, and lactates, SOFA shows an incremental prognostic ability both at T0 (RR 1.165, IC 95% 1.009-1.224, p < 0.0001) and T1 (RR 1.168, IC 95% 1.104-1.234, p < 0.0001). SOFA score shows a moderate prognostic stratification ability, and demonstrates an incremental prognostic value over the previous medical conditions and clinical parameters in septic patients.
几种常用于脓毒症患者的评分系统已经在 ICU 环境中得到验证,但可能不适用于其他环境,如急诊科 (ED) 或高依赖病房 (HDU),因为这些患者中有相当一部分在这些环境中得到管理。本研究的目的是寻找适用于 ED-HDU 中管理的脓毒症患者预后评估的可靠工具。在 2008 年 6 月至 2016 年 4 月期间,742 名被诊断为脓毒症/严重脓毒症/脓毒性休克、未插管、收入 ED 的患者中,在 ED 入院时(T0)计算 SOFA、qSOFA、PIRO、MEWS、Charlson 合并症指数、MEDS 和 APACHE II;在 ED-高依赖病房入住 24 小时后(T1)也计算 SOFA 和 MEWS。测试 SOFA 评分与人口统计学数据和脓毒症严重程度参数相比的区分度和增量预后价值。主要结局是 28 天死亡率。28 天死亡率为 31%。不同的评分显示出适度到中度的区分度(T0 SOFA 0.695;T1 SOFA 0.741;qSOFA 0.625;T0 MEWS 0.662;T1 MEWS 0.729;PIRO:0.646;APACHE II 0.756;Charlson 合并症指数 0.596;MEDS 0.674,均 p<0.001)。在多变量逐步 Cox 分析中,包括年龄、Charlson 合并症指数、MEWS 和乳酸,SOFA 在 T0(RR 1.165,95%CI 1.009-1.224,p<0.0001)和 T1(RR 1.168,95%CI 1.104-1.234,p<0.0001)均显示出增量预后能力。SOFA 评分显示出适度的预后分层能力,并在脓毒症患者中显示出优于先前的医疗条件和临床参数的增量预后价值。